- Home
- SER vs GUTS Comparison
SER vs GUTS Comparison
Compare SER & GUTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SER
- GUTS
- Stock Information
- Founded
- SER 2017
- GUTS 2010
- Country
- SER United States
- GUTS United States
- Employees
- SER N/A
- GUTS N/A
- Industry
- SER Biotechnology: Pharmaceutical Preparations
- GUTS
- Sector
- SER Health Care
- GUTS
- Exchange
- SER Nasdaq
- GUTS NYSE
- Market Cap
- SER 56.5M
- GUTS 58.8M
- IPO Year
- SER 2018
- GUTS 2024
- Fundamental
- Price
- SER $5.80
- GUTS $1.58
- Analyst Decision
- SER Strong Buy
- GUTS Buy
- Analyst Count
- SER 1
- GUTS 1
- Target Price
- SER $11.00
- GUTS $10.00
- AVG Volume (30 Days)
- SER 16.6K
- GUTS 930.5K
- Earning Date
- SER 08-08-2025
- GUTS 08-13-2025
- Dividend Yield
- SER N/A
- GUTS N/A
- EPS Growth
- SER N/A
- GUTS N/A
- EPS
- SER N/A
- GUTS N/A
- Revenue
- SER $51,000.00
- GUTS $60,000.00
- Revenue This Year
- SER N/A
- GUTS N/A
- Revenue Next Year
- SER N/A
- GUTS N/A
- P/E Ratio
- SER N/A
- GUTS N/A
- Revenue Growth
- SER N/A
- GUTS N/A
- 52 Week Low
- SER $3.81
- GUTS $0.87
- 52 Week High
- SER $11.57
- GUTS $4.92
- Technical
- Relative Strength Index (RSI)
- SER 57.53
- GUTS 42.52
- Support Level
- SER $5.50
- GUTS $1.54
- Resistance Level
- SER $6.29
- GUTS $1.82
- Average True Range (ATR)
- SER 0.52
- GUTS 0.18
- MACD
- SER 0.03
- GUTS -0.07
- Stochastic Oscillator
- SER 74.44
- GUTS 5.06
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.
About GUTS FRACTYL HEALTH INC
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.